.png)
Advancing Clinical Research for Emerging Therapeutic Technologies
SVG Pharma is a specialised Australian CRO leveraging advanced technologies to deliver efficient, tailored, and cost-effective clinical trials — from study design to regulatory submission — across plant-based therapeutics, microbiome interventions, and mental health treatments.
Founded in 2020
GMP & GACP aligned
Australian-based
We are an Australian Contract Research Organisation (CRO) dedicated to advancing emerging therapeutic technologies.
Our expertise spans clinical research design, regulatory strategy, and operational delivery for novel treatments in plant-based medicines, microbiome science, and mental health therapeutics.
​
We operate at the intersection of science and technology, combining AI-enabled tools, advanced data systems, and clinical insight to streamline research, reduce costs, and enhance study precision.
​
Our lean and agile model allows us to deliver tailored research solutions that meet the unique needs of each sponsor — from early-stage programs through to late-phase trials and regulatory submission.
Why Choose Us
From trial design to regulatory submission, SVG Pharma delivers clinical research that advances emerging therapeutic technologies with efficiency, scientific rigour, and purpose. Our work is defined by deep expertise, proven capability, and a steadfast commitment to integrity.
Specialist Expertise
Our team brings decades of combined experience in emerging therapeutic research, clinical operations, and regulatory compliance — with a strong foundation in medicinal cannabis, microbiome, and mental health research.
Efficient Delivery
We operate with a lean, agile model designed for cost-efficient and timely trial delivery. Our approach integrates smart processes, technology, and experienced project management to achieve high-quality outcomes at lower operational cost. This efficiency has been proven across late-phase and complex clinical studies, enabling sponsors to advance programs with confidence and value.
Scientific Integrity
Every project we undertake is grounded in evidence-based methodology, prioritising data quality, regulatory alignment, and patient outcomes. We uphold the highest standards of transparency, ethics, and scientific excellence.
Global Support, Local Expertise
We partner with sponsors worldwide to generate robust, regulator-ready evidence that accelerates market access for innovative therapies.
With a deep understanding of Australian and international regulatory standards, we support cross-border studies and multi-jurisdictional submissions with confidence and clarity.
Patient & Ethical Focus
Patient safety and ethical integrity are central to every study we conduct. Our trials are designed and executed with strict ethical oversight, ensuring participant wellbeing, data integrity, and regulatory compliance at every stage.
​​
We are committed to conducting research that not only meets scientific and commercial objectives, but also upholds the highest standards of responsibility and transparency.
COMPANY UPDATE
Milestone Achieved: Completion of CBD Oil Study for IBS Pain
January 2025
​
SVG Pharma has successfully completed the Genesis study, a clinical evaluation of a CBD oil formulation for managing abdominal pain in patients with Irritable Bowel Syndrome (IBS).
​
The study data currently supports an upcoming Schedule 3 submission to the Therapeutic Goods Administration (TGA).
​
This milestone underscores SVG’s commitment to advancing credible, evidence-based natural therapeutics.
This study does not promote any unapproved product; future availability is subject to TGA assessment and approval.